MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CARBOXYMALTOSE FERRIQUE ET CIPROFLOXACINE INJECTABLE
Awarded
The competition has ended and a winner has been selected.
- Deadline
- Jan 6,Expired
- Agreement
- Framework agreement
Brief
Le Centre hospitalier de Valenciennes a attribué un marché spécifique à BAYER HEALTHCARE SAS pour la fourniture de médicaments, notamment du carboxymaltose ferrique et de la ciprofloxacine injectable. Le contrat, de type accord-cadre, a été attribué sur la base du prix et de la technique, et deux offres ont été reçues.
Farmasøytisk engroshandel
Result
- BAYER HEALTHCAREWinner
- 2Number of tenders received
- Not statedContract value
- Maximum framework agreement valueUp to €248,772
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Prix et technique
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Centre Hospitalier de Valenciennes
From the notice
MARCHE SPECIFIQUEN°2 MEDICAMENT GCS PHDF 2025 : CARBOXYMALTOSE FERRIQUE ET CIPROFLOXACINE INJECTABLE
Contact
D'Hon Nicolas - Responsable de la cellule des marchés publicsdhont-n@ch-valenciennes.fr- Result · Framework agreementType
- NordLocation
- 33690000Main codeVarious medicinal products